Morgan Stanley reiterated its overweight rating on Dalmia Bharat, while Macquarie advised an outperform rating for Axis Bank. Jefferies sustained a hold rating on Kotak Mahindra Bank, and Investec endorsed a buy rating for Aurobindo Pharma.
Small cap stocks surged at the end of 2023, as expectations grew that the Fed was done raising interest rates and would soon begin easing
The unexpected move is also seen bringing down yields on short-term government bonds, as the three securities that the government has chosen to buy back
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003